Prothena Corporation plc
NASDAQ:PRTA
16.46 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 91.37 | 53.905 | 200.577 | 0.853 | 0.814 | 0.955 | 27.519 | 1.055 | 1.607 | 50.854 | 0.676 | 2.658 | 0.507 | 1.243 |
Cost of Revenue
| 8.412 | 6.741 | 82.284 | 74.884 | 50.836 | 101.183 | 134.547 | 119.534 | 58.439 | 38.452 | 26.052 | 34.139 | 0 | 0 |
Gross Profit
| 82.958 | 47.164 | 118.293 | -74.031 | -50.022 | -100.228 | -107.028 | -118.479 | -56.832 | 12.402 | -25.376 | -31.481 | 0.507 | 1.243 |
Gross Profit Ratio
| 0.908 | 0.875 | 0.59 | -86.789 | -61.452 | -104.951 | -3.889 | -112.302 | -35.365 | 0.244 | -37.538 | -11.844 | 1 | 1 |
Reseach & Development Expenses
| 220.571 | 135.562 | 82.284 | 74.884 | 50.836 | 101.183 | 134.547 | 119.534 | 58.439 | 38.452 | 26.052 | 34.139 | 24.172 | 9.787 |
General & Administrative Expenses
| 61.835 | 49.9 | 46.318 | 38.703 | 35.736 | 42.482 | 48.226 | 41.056 | 23.105 | 19.051 | 15.051 | 9.929 | 5.579 | 3.618 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 61.835 | 49.9 | 46.318 | 38.703 | 35.736 | 42.482 | 48.226 | 41.056 | 23.105 | 19.051 | 15.051 | 9.929 | 5.579 | 3.618 |
Other Expenses
| -0.458 | 5.952 | -0.054 | 1.307 | 8.399 | 2.74 | -2.349 | 0.571 | 0.026 | 0.31 | -0.225 | 0 | 0 | 0 |
Operating Expenses
| 282.406 | 185.462 | 128.602 | 113.587 | 86.572 | 143.665 | 182.773 | 160.59 | 81.544 | 57.503 | 41.103 | 44.068 | 29.751 | 13.405 |
Operating Income
| -191.036 | -131.557 | 71.975 | -112.734 | -85.697 | -158.855 | -155.254 | -159.535 | -79.937 | -6.649 | -40.427 | -41.41 | -29.244 | -12.162 |
Operating Income Ratio
| -2.091 | -2.441 | 0.359 | -132.162 | -105.279 | -166.34 | -5.642 | -151.218 | -49.743 | -0.131 | -59.803 | -15.579 | -57.68 | -9.784 |
Total Other Income Expenses Net
| 30.556 | 5.952 | -0.054 | 1.307 | 8.399 | -13.405 | -2.349 | 0.571 | 0.026 | 0.31 | -0.225 | 0.005 | 0 | 0 |
Income Before Tax
| -160.48 | -125.605 | 71.921 | -111.427 | -77.298 | -156.115 | -157.603 | -158.964 | -79.911 | -6.339 | -40.581 | -41.405 | -29.244 | -12.162 |
Income Before Tax Ratio
| -1.756 | -2.33 | 0.359 | -130.63 | -94.961 | -163.471 | -5.727 | -150.677 | -49.727 | -0.125 | -60.031 | -15.578 | -57.68 | -9.784 |
Income Tax Expense
| -13.452 | -8.656 | 4.946 | -0.283 | 0.379 | -0.47 | -4.366 | 1.144 | 0.701 | 0.811 | 0.415 | 0.006 | 0.426 | 0.32 |
Net Income
| -147.028 | -116.949 | 66.975 | -111.144 | -77.677 | -155.645 | -153.237 | -160.108 | -80.612 | -7.15 | -40.996 | -41.411 | -29.67 | -12.482 |
Net Income Ratio
| -1.609 | -2.17 | 0.334 | -130.298 | -95.426 | -162.979 | -5.568 | -151.761 | -50.163 | -0.141 | -60.645 | -15.58 | -58.521 | -10.042 |
EPS
| -2.76 | -2.47 | 1.51 | -2.78 | -1.95 | -3.93 | -4.07 | -4.66 | -2.66 | -0.29 | -2.2 | -2.84 | -1.68 | -0.71 |
EPS Diluted
| -2.76 | -2.47 | 1.38 | -2.78 | -1.95 | -3.93 | -4.07 | -4.66 | -2.66 | -0.29 | -2.2 | -2.84 | -1.68 | -0.71 |
EBITDA
| -190.108 | -131.557 | 71.975 | -112.734 | -85.819 | -126.565 | -155.254 | -159.535 | -79.937 | -6.649 | -40.427 | -41.41 | -28.853 | -11.971 |
EBITDA Ratio
| -2.081 | -2.441 | 0.359 | -132.162 | -105.429 | -132.529 | -5.642 | -151.218 | -49.743 | -0.131 | -59.803 | -15.579 | -56.909 | -9.631 |